{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:10:34Z","timestamp":1785168634968,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ackdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1053\/j.ackd.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T02:30:14Z","timestamp":1440383414000},"page":"361-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hyponatremia in Cirrhosis\u2014Pathogenesis, Treatment, and Prognostic Significance"],"prefix":"10.1053","volume":"22","author":[{"given":"Vikash K.","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/gastro\/got037","article-title":"Hyponatraemia and cirrhosis","volume":"2","author":"Gianotti","year":"2014","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib4","first-page":"58","article-title":"Paradoxical hyponatremia associated with congestive heart failure and with cirrhosis of the liver","volume":"5","author":"Talso","year":"1956","journal-title":"Metabolism"},{"issue":"10","key":"10.1053\/j.ackd.2015.02.002_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec's cirrhosis","volume":"32","author":"Kowalski","year":"1953","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2015.02.002_bib6","series-title":"Hemodynamic and Hormonal Alterations in Hepatic Cirrhosis","author":"Schrier","year":"1988"},{"key":"10.1053\/j.ackd.2015.02.002_bib7","series-title":"Hepatic and Systemic Hemodynamics and Neurohormonal System in Cirrhosis","author":"Bosch","year":"1988"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0016-5085(92)91118-N","article-title":"Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats","volume":"103","author":"Sieber","year":"1992","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib9","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/0016-5085(93)90655-V","article-title":"Role of nitric oxide in the in\u00a0vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats","volume":"104","author":"Sieber","year":"1993","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/0016-5085(92)91451-9","article-title":"Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition","volume":"103","author":"Pizcueta","year":"1992","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1476-5381.1992.tb14233.x","article-title":"Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension","volume":"105","author":"Pizcueta","year":"1992","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.1840150227","article-title":"Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide","volume":"15","author":"Claria","year":"1992","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0014-2999(90)90062-B","article-title":"Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in\u00a0vivo","volume":"182","author":"Thiemermann","year":"1990","journal-title":"Eur J Pharmacol"},{"issue":"24","key":"10.1053\/j.ackd.2015.02.002_bib14","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1073\/pnas.87.24.10043","article-title":"Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells","volume":"87","author":"Radomski","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8744","key":"10.1053\/j.ackd.2015.02.002_bib15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(91)91384-7","article-title":"Hyperdynamic circulation in cirrhosis: a role for nitric oxide?","volume":"337","author":"Vallance","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2015.02.002_bib16","series-title":"Endotoxin and Renal Dysfunction in Liver Disease","author":"Bourgoignie","year":"1988"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.1840080207","article-title":"Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis","volume":"8","author":"Lumsden","year":"1988","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ackd.2015.02.002_bib18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.1840180520","article-title":"Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia","volume":"18","author":"Guarner","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7326\/0003-4819-94-2-198","article-title":"Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites","volume":"94","author":"Arroyo","year":"1981","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ackd.2015.02.002_bib20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/hep.1840160510","article-title":"Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor","volume":"16","author":"Henriksen","year":"1992","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ackd.2015.02.002_bib21","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/0016-5085(93)90360-O","article-title":"Circulating levels of endothelin in cirrhosis","volume":"104","author":"Asbert","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/j.ackd.2015.02.002_bib22","first-page":"153","article-title":"The mechanism of ascites formation in chronic liver disease","volume":"30","author":"Atkinson","year":"1961","journal-title":"Q J Med"},{"key":"10.1053\/j.ackd.2015.02.002_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1749-6632.1970.tb37014.x","article-title":"The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis: the \u201coverflow\u201d theory of ascites formation","volume":"170","author":"Lieberman","year":"1970","journal-title":"Ann New York Acad Sci"},{"issue":"5","key":"10.1053\/j.ackd.2015.02.002_bib24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"8","key":"10.1053\/j.ackd.2015.02.002_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gut.24.8.761","article-title":"Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation","volume":"24","author":"Bernardi","year":"1983","journal-title":"Gut"},{"issue":"10","key":"10.1053\/j.ackd.2015.02.002_bib26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/gut.25.10.1034","article-title":"Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis","volume":"25","author":"Henriksen","year":"1984","journal-title":"Gut"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0016-5085(87)90911-5","article-title":"Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis","volume":"93","author":"Camps","year":"1987","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2362.1983.tb00100.x","article-title":"Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion","volume":"13","author":"Arroyo","year":"1983","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib29","first-page":"219","article-title":"Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography","volume":"17","author":"Sacerdoti","year":"1993","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.1984.136","article-title":"Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis","volume":"26","author":"Perez-Ayuso","year":"1984","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01095898","article-title":"Prognostic value of spontaneous hyponatremia in cirrhosis with ascites","volume":"21","author":"Arroyo","year":"1976","journal-title":"Am J Dig Dis"},{"key":"10.1053\/j.ackd.2015.02.002_bib32","series-title":"Examination of Kidney Function","author":"Sch\u00fcck","year":"1984"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib33","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/0016-5085(85)90664-X","article-title":"Derangements of renal water handling in liver disease","volume":"89","author":"Epstein","year":"1985","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1053\/j.ackd.2015.02.002_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-96-4-413","article-title":"Role of vasopressin in abnormal water excretion in cirrhotic patients","volume":"96","author":"Bichet","year":"1982","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib35","first-page":"155","article-title":"Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis","volume":"10","author":"Epstein","year":"1984","journal-title":"Miner Electrolyte Metab"},{"key":"10.1053\/j.ackd.2015.02.002_bib36","series-title":"Disturbances in Body Fluid Osmolality","first-page":"125","article-title":"Osmotic control of vasopressin function","author":"Robertson","year":"1977"},{"issue":"suppl 217","key":"10.1053\/j.ackd.2015.02.002_bib37","first-page":"A164","article-title":"The effect of isoproterenol on vasopressin secretion","volume":"94","author":"Robertson","year":"1974","journal-title":"Endocrinology"},{"issue":"2 Pt 2","key":"10.1053\/j.ackd.2015.02.002_bib38","first-page":"R349","article-title":"Adaptive resetting of the volume control of vasopressin secretion during sustained hypovolemia","volume":"268","author":"Iwasaki","year":"1995","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(91)90222-7","article-title":"Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites","volume":"100","author":"Claria","year":"1991","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1053\/j.ackd.2015.02.002_bib40","first-page":"F315","article-title":"A micropuncture study of salt and water retention in chronic experimental cirrhosis","volume":"232","author":"Lopez-Novoa","year":"1977","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/hep.1840140205","article-title":"A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients","volume":"14","author":"Gatta","year":"1991","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.ackd.2015.02.002_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0016-5085(83)90135-X","article-title":"Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting","volume":"84","author":"Reznick","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1053\/j.ackd.2015.02.002_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0002-9343(65)90042-2","article-title":"Renal failure in patients with cirrhosis of the liver. Ii. Factors influencing maximal urinary flow rate","volume":"39","author":"Shear","year":"1965","journal-title":"Am J Med"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(79)90268-3","article-title":"Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease","volume":"77","author":"Boyer","year":"1979","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1053\/j.ackd.2015.02.002_bib45","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1172\/JCI117728","article-title":"Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study","volume":"95","author":"Videen","year":"1995","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ackd.2015.02.002_bib47","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0016-5085(94)90552-5","article-title":"Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy","volume":"107","author":"Haussinger","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/j.ackd.2015.02.002_bib48","series-title":"Fluid and Electrolytes Disorders and the Central Nervous System","author":"Fraser","year":"1987"},{"key":"10.1053\/j.ackd.2015.02.002_bib49","series-title":"Hyponatremia and Hypernatremia in Liver Disease","author":"Papadakis","year":"1988"},{"issue":"8","key":"10.1053\/j.ackd.2015.02.002_bib50","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/gut.2007.122176","article-title":"Pathogenetic mechanisms of hepatic encephalopathy","volume":"57","author":"Haussinger","year":"2008","journal-title":"Gut"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib51","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/hep.21235","article-title":"Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis","volume":"43","author":"Haussinger","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ackd.2015.02.002_bib52","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0168-8278(01)00181-7","article-title":"The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation","volume":"35","author":"Cordoba","year":"2001","journal-title":"J Hepatol"},{"issue":"4","key":"10.1053\/j.ackd.2015.02.002_bib53","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/hep.21114","article-title":"Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy","volume":"43","author":"Kale","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib54","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11011-010-9172-3","article-title":"Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence","volume":"25","author":"Cordoba","year":"2010","journal-title":"Metab Brain Dis"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib56","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/lt.20329","article-title":"Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone","volume":"11","author":"Ruf","year":"2005","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.20517","article-title":"Serum sodium predicts mortality in patients listed for liver transplantation","volume":"41","author":"Biggins","year":"2005","journal-title":"Hepatology"},{"issue":"10","key":"10.1053\/j.ackd.2015.02.002_bib59","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2015.02.002_bib60","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","article-title":"Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation","volume":"130","author":"Londono","year":"2006","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1053\/j.ackd.2015.02.002_bib61","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/lt.21154","article-title":"The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study","volume":"13","author":"Dawwas","year":"2007","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1053\/j.ackd.2015.02.002_bib62","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.22846","article-title":"Impact of pretransplant hyponatremia on outcome following liver transplantation","volume":"49","author":"Yun","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"10.1053\/j.ackd.2015.02.002_bib63","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1478-3231.2009.01982.x","article-title":"Effect of hyponatraemia on outcomes following orthotopic liver transplantation","volume":"29","author":"Hackworth","year":"2009","journal-title":"Liver Int"},{"issue":"11 suppl 1","key":"10.1053\/j.ackd.2015.02.002_bib64","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib65","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/00007890-198912000-00023","article-title":"Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium","volume":"48","author":"Wszolek","year":"1989","journal-title":"Transplantation"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1399-0012.1998.tb01102.x","article-title":"Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis","volume":"12","author":"Abbasoglu","year":"1998","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2015.02.002_bib67","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":"Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial","volume":"124","author":"Gerbes","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib68","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","author":"Gines","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib69","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1172\/JCI116881","article-title":"Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men","volume":"92","author":"Ohnishi","year":"1993","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1053\/j.ackd.2015.02.002_bib70","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.ki.5000432","article-title":"Vasopressin receptor antagonists","volume":"69","author":"Greenberg","year":"2006","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2015.02.002_bib71","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/hep.21901","article-title":"Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome","volume":"46","author":"Krag","year":"2007","journal-title":"Hepatology"},{"issue":"20","key":"10.1053\/j.ackd.2015.02.002_bib72","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2015.02.002_bib73","unstructured":"US Food and Drug Administration. Samsca (Tolvaptan): Drug safety communication\u2014FDA limits duration and usage due to possible liver injury leading to organ transplant or death. In: Administration USFaD, ed. 2013. http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm350185.htm. Accessed April\u00a02013."},{"issue":"25","key":"10.1053\/j.ackd.2015.02.002_bib74","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2015.02.002_bib75","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","article-title":"A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial","volume":"37","author":"Wong","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib77","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","article-title":"Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial","volume":"48","author":"Gines","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ackd.2015.02.002_bib78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2011-300157","article-title":"Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"issue":"7","key":"10.1053\/j.ackd.2015.02.002_bib79","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/apt.12025","article-title":"Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia","volume":"36","author":"Dahl","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1053\/j.ackd.2015.02.002_bib80","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis","volume":"56","author":"Cardenas","year":"2012","journal-title":"J Hepatol"},{"issue":"10","key":"10.1053\/j.ackd.2015.02.002_bib81","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2215\/CJN.03530411","article-title":"Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience","volume":"6","author":"Higashihara","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"10.1053\/j.ackd.2015.02.002_bib82","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1001\/jama.1980.03300500039026","article-title":"Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients","volume":"243","author":"Miller","year":"1980","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ackd.2015.02.002_bib83","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gut.31.2.204","article-title":"Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites","volume":"31","author":"McCormick","year":"1990","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1053\/j.ackd.2015.02.002_bib84","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0168-8278(07)61830-3","article-title":"Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial","volume":"46","author":"Jalan","year":"2007","journal-title":"J Hepatol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T03:53:08Z","timestamp":1748577188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559515000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1548559515000361"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2015.02.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyponatremia in Cirrhosis\u2014Pathogenesis, Treatment, and Prognostic Significance","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2015.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}